In Japan, the governmental recommnendation of HPV vaccine has been suspended since June 2013, due to media reports of alleged adverse vaccination events. Although evidence of effectiveness and safety of the HPV vaccine has been universally demonstrated, and the medical and academic organizations across Japan have requested the resumption of the government’s recommendation, the Japanese government has not changed their official stance towards the HPV vaccine. Under the current suspension of the national government’s recommendation, one local government Isumi City started sending a leaflet containing information of cervical cancer and HPV vaccine, but not recommendation for the vaccine, to the tagted girls born in the fiscal year (FY) 2003. The cumulative vaccination rate of them reached 10.07% (14/139), which was significantly higher than that (0.00%) for girls born in FY 2002 who did not receive such a leaflet (p < 0.001). We sincerely ask the national government to change their stance towards the HPV vaccine. We also strongly suggest that, in the meantime, local governments immediately begin to provide an appropriate information of cervical cancer and HPV vaccine to the targeted girls and their parents in a way similar to what Isumi City has now shown to be effective.

在日本，由于媒体报道了所谓的不良疫苗接种事件，政府自 2013 年 6 月起暂停了对 HPV 疫苗的推荐。尽管HPV疫苗的有效性和安全性的证据已得到普遍证明，日本各地的医疗和学术组织也要求恢复政府的推荐，但日本政府并没有改变对HPV疫苗的官方立场。在国家政府目前暂停推荐的情况下，当地政府 Isumi 市开始向 2003 财政年度 (FY) 出生的标记女孩发送包含宫颈癌和 HPV 疫苗信息但不推荐疫苗的传单。累计接种率达到10.07%（14/139），明显高于（0.p  < 0.001)。我们真诚地要求国家政府改变对HPV疫苗的立场。我们也强烈建议，与此同时，地方政府立即开始向目标女孩及其父母提供适当的宫颈癌和 HPV 疫苗信息，类似于现在 Isumi 市已证明有效的方式。